temozolomide has been researched along with 3-methyladenine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Germano, IM; Ito, H; Kanzawa, T; Komata, T; Kondo, S; Kondo, Y | 1 |
Cheng, Y; Huang, N; Huang, Q; Tan, Y; Tang, M; Zhang, P; Zhang, X; Zhao, G | 1 |
Balachandar, A; Bhagirath, E; Pandey, S; Vegh, C; Wear, D | 1 |
3 other study(ies) available for temozolomide and 3-methyladenine
Article | Year |
---|---|
Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells.
Topics: Adenine; Antineoplastic Agents, Alkylating; Apoptosis; Autophagy; Cell Cycle; Cell Line, Tumor; Cell Survival; Dacarbazine; Dose-Response Relationship, Drug; Glioma; Humans; Macrolides; Microtubule-Associated Proteins; Organelles; Temozolomide | 2004 |
Combination of 3-methyladenine therapy and Asn-Gly-Arg (NGR)-modified mesoporous silica nanoparticles loaded with temozolomide for glioma therapy in vitro.
Topics: Adenine; Animals; Antineoplastic Agents; Apoptosis; Autophagy; Drug Carriers; Drug Delivery Systems; Glioma; Nanoparticles; Oligopeptides; Rats; Silicon Dioxide; Temozolomide | 2019 |
Autophagy Inhibition via Hydroxychloroquine or 3-Methyladenine Enhances Chemotherapy-Induced Apoptosis in Neuro-Blastoma and Glioblastoma.
Topics: Antineoplastic Agents; Apoptosis; Autophagy; Brain Neoplasms; Cell Line, Tumor; Child; Cisplatin; Glioblastoma; Humans; Hydroxychloroquine; Infant; Neuroblastoma; Temozolomide | 2023 |